• 

  UK Health Services Says Leqembi Is Too Costly, Too Risky to Cover
• 

  Despite New Spin, Obesity and Diabetes Drug Failed Alzheimer’s Trial
• 

  An Unexpected Way to Lower Your Dementia Risk: Pet Ownership
• 

  What Happens When Insurance Refuses to Cover Your Alzheimer’s Prescription?
• 

  AAIC: Experts Discuss the Future of Alzheimer’s Treatments
• 

  Updates on Alzheimer’s Drug Research from AAIC 2024
• 

  AAIC: Optimism for Alzheimer’s Blood Tests
• 

  EU Regulators Reject Alzheimer’s Drug Leqembi
• 

  TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2024.02)
• 

  Drinking and Brain Health: Is There a ‘Healthy’ Amount of Alcohol?
• 

  How Do You Explain Dementia to a Child? 6 Things to Try
• 

  STUDY: In Menopause, Estrogen Drops — Here’s How the Brain Reacts
• 

  Considering Enrolling in a Dementia Clinical Trial? 6 Things You Should Know
• 

  How Do Alzheimer’s Clinical Trials Work? And Other FAQs
• 

  FDA Approves New Alzheimer’s Drug Kisunla (Donanemab)

Previous131415Next